RAC 2.92% $1.94 race oncology ltd

Ann: Change in substantial holding, page-75

  1. 8,405 Posts.
    lightbulb Created with Sketch. 1383
    Dr T. 31/03/2020:

    "I think the high cost biologics like CAR-T are going to struggle commercially even if they succeed medically. More importantly, I think this is what the large pharma companies are thinking too."

    He made no comment on any particular company.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.